DOCSLIB.ORG

Secondary Pneumothorax in End-Stage Lung Disease Complicated by Noninvasive Ventilation and a Persistent Air Leak

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Secondary Pneumothorax in End-Stage Lung Disease Complicated by Noninvasive Ventilation and a Persistent Air Leak David J. McCracken1,2, Eihab O. Bedawi1,2, Maged Hassan 1,2, [email protected] Dionisios Stavroulias3, Najib M. Rahman1,2 1Oxford Pleural Unit, Churchill Hospital, Oxford, UK. 2Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, UK. 3Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Secondary pneumothorax in end-stage lung disease complicated by noninvasive ventilation and a persistent air leak Cite as: McCracken DJ, Bedawi EO, Hassan M, et al. Case report Secondary pneumothorax in end-stage lung disease complicated by noninvasive ventilation and a persistent air leak. Breathe 2018; 14: A 75-year-old man initially presented to the (NIV) was required due to progressive symptomatic e119–e122. respiratory service in 2012 with severe chronic hypercapnic respiratory failure including a carbon obstructive pulmonary disease (COPD) defined dioxide tension (PCO2) of 7.9 kPa and bicarbonate as Global Initiative for Chronic Obstructive Lung of 28.3 mmol·L−1. Disease stage 3. Forced expiratory volume in 1 s (FEV1) was 1.1 L (33% predicted) with FEV1/ Task 1 forced vital capacity 32%. He required long-term What is the role of long-term NIV in hypercapnic oxygen therapy at home at 4 L·min−1 and by 2015 respiratory failure secondary to COPD? nocturnal high-pressure noninvasive ventilation @ERSpublications Pneumothorax is a well-recognised complication of end-stage COPD, but the management is often complex and may be complicated by other sequelae of advanced respiratory 2019 disease including the requirement for NIV http://ow.ly/vkoJ30mB4nZ https://doi.org/10.1183/20734735.027318 Breathe | December 2018 | Volume 14 | No 4 e119 Secondary pneumothorax in end-stage lung disease Answer 1 Answer 2 Recurrent exacerbations are characteristic The British Thoracic Society pleural disease of COPD and may lead to respiratory failure guidelines (2010) suggest first line use of small- requiring ventilatory support. The use of NIV in bore chest tubes (<14 Fr) in pneumothoraces this setting became an established treatment requiring drainage [3]. This is largely based on for acute exacerbations in the early 2000s; the perceived increase in pain associated with however, clinical trials such as the RESCUE trial, larger drains, along with the risk of serious initially failed to demonstrate improvements complications such as malposition, visceral in hypercapnia or mortality with domiciliary injury or infective complications such as use [1]. The HOT-HMV trial [2], published in empyema. The documented efficacy of small- 2017, demonstrated statistically significant bore drains is adequate to suggest their use, and improvements in time to readmission or while many of the studies directly comparing death in patients treated with oxygen and NIV the use of small-bore and large-bore chest at home when compared with those treated drains are limited by their retrospective nature with oxygen alone, which in contrast to and small patient numbers, none demonstrate previous studies justified its use. There were any statistically significant difference in also reductions in frequency of exacerbations efficacy. Expert consensus would therefore and improvements in health-related quality suggest that small-bore drains should generally of life scores at 3 months but no difference in be used in pneumothorax management, but all-cause mortality [2]. Use of domiciliary NIV that it may be necessary to consider a large- in COPD therefore remains contentious, but bore drain in cases of a blocked small drain would appear to result in symptomatic benefit resulting in tension pneumothorax, or in cases in a subset of patients along with probable where an air leak is not adequately controlled reductions in readmission rates. despite the use of thoracic suction. The patient was admitted in December 2017 After 1 week of inpatient management, an air with a large symptomatic left-sided secondary leak persisted with incomplete apposition of the spontaneous pneumothorax causing respiratory lung. The patient was deemed unfit for surgical compromise and surgical emphysema. Initial intervention and therefore a Heimlich valve management was with an 18 Fr apical chest was applied to allow for ambulatory, outpatient drain inserted in the emergency department with management. Over 4 weeks, the patient attended good symptomatic and radiological improvement. for weekly review. Functional capacity increased A persistent air leak remained and NIV was and the air leak was measured objectively as 150– temporarily discontinued. 180 mL·min−1 using a digital suction device (Thopaz; Medela UK Ltd, Manchester, UK). Task 2 The patient developed early morning headaches What size of intercostal chest drain is and daytime somnolence with PCO2 rising to appropriate for the initial management of a 8.5 kPa. NIV was recommenced with chest secondary spontaneous pneumothorax? radiography and Thopaz reassessment to ensure no worsening pneumothorax. Improvements in PCO2 and symptoms resulted, radiological appearances were unchanged and objective air leak remained at 180–200 mL·min−1. Task 3 How does long-term NIV use influence pneumothorax management and what methods are available to assess this objectively? e120 Breathe | December 2018 | Volume 14 | No 4 Secondary pneumothorax in end-stage lung disease Answer 3 Answer 4 Thopaz is a digital suction device that allows Several methods are available in the for accurate objective air leak measurement management of persistent air leak including in pneumothorax management. It is a novel a surgical approach, endobronchial valve option to guide management and may placement, medical pleurodesis or ambulatory have a role in risk stratification. This role is management. In some cases, transplant could currently under investigation in the ongoing also be considered, although in this case age randomised ambulatory management of and deconditioning were significant relative primary pneumothorax (RAMPP) trial (https:// contraindications. A number of pleurodesis doi.org/10.1186/ISRCTN79151659) in order agents are available, with talc the most to assess whether a large air leak can predict commonly used in the UK, as it is recognised those patients whose pneumothorax is unlikely as being relatively safe with an apparently to resolve and therefore require earlier surgical low pneumothorax recurrence rate. Evidence intervention. underpinning the relative success rates The effect of NIV on a persistent air leak is between agents, however, is limited by the unclear with no evidence to suggest impaired paucity of quality data [4]. resolution; physiologically, it is likely that Autologous blood can be used and is the the positive airway pressure is significantly pleurodesis agent of choice for the authors attenuated and not transmitted to the pleural in cases of persistent air leak such as this, surface and peripheral lung parenchyma. due to a previous case of severe pneumonitis However, NIV was temporarily discontinued resulting in the death of the patient following due to the perceived association between talc administration. The suggested method of positive pressure ventilation and barotrauma action is also thought to be different with the or volutrauma. In this case, objectively theoretical sealing of the air leak as opposed measured air leak was unchanged irrespective to the conventional adhesion of visceral and of ventilator use and following a symptomatic parietal pleura. Two reviews have suggested deterioration, NIV was recommenced. improvements when blood pleurodesis is compared with prolonged conservative To facilitate the patient’s wishes for drain removal, management [5]. A theoretical risk exists with he was readmitted for blood patch pleurodesis regards to pleural infection; however, only a which was performed on three occasions but was single case of subsequent pleural infection has unsuccessful. Air leak persisted at >100 mL·min−1 been identified from published case series [6]. so the patient was discharged with a Heimlich valve There are few absolute contraindications for further ambulatory follow-up. At the time of to a surgical approach; however, the primary writing, 5 months after initial presentation, the contraindications arise from anaesthetic risk patient remains under regular ongoing follow-up and the requirement to maintain single lung with a persistent air leak. ventilation throughout the procedure. Elective patients with a higher than average risk require a multidisciplinary approach including Task 4 optimisation by the “pre-habilitation” nurses What options are available in the management and an anaesthetic assessment which may of patients with a persistent air leak? result in further investigations to fully define this operative risk. In these cases, patients are informed of the increased risk of morbidity and mortality including the potential to worsen their quality of life and must understand and accept this before surgery will be offered. Breathe | December 2018 | Volume 14 | No 4 e121 Secondary pneumothorax in end-stage lung disease Both surgery and endobronchial valve placement be technically difficult and would carry a higher risk were ultimately excluded in this case due to the of post-operative prolonged air leak given the extent significant associated peri-operative anaesthetic of the emphysematous changes seen on computed risk, predominantly as a result of this patient’s severe tomography and the subsequent lack of normal lung hypercapnic respiratory failure. Surgery would also tissue on which to place the resection line. Key
Load more

Recommended publications
  • 2014 05 08 BMJ Spontaneous Pneumothorax.Pdf
    BMJ 2014;348:g2928 doi: 10.1136/bmj.g2928 (Published 8 May 2014) Page 1 of 7 Clinical Review CLINICAL REVIEW Spontaneous pneumothorax Oliver Bintcliffe clinical research fellow, Nick Maskell consultant respiratory physician Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol BS10 5NB, UK Pneumothorax describes the presence of gas within the pleural and mortality than primary pneumothorax, in part resulting from space, between the lung and the chest wall. It remains a globally the reduction in cardiopulmonary reserve in patients with important health problem, with considerable associated pre-existing lung disease. morbidity and healthcare costs. Without prompt management Tension pneumothorax is a life threatening complication that pneumothorax can, occasionally, be fatal. Current research may requires immediate recognition and urgent treatment. Tension in the future lead to more patients receiving ambulatory pneumothorax is caused by the development of a valve-like leak outpatient management. This review explores the epidemiology in the visceral pleura, such that air escapes from the lung during and causes of pneumothorax and discusses diagnosis, evidence inspiration but cannot re-enter the lung during expiration. This based management strategies, and possible future developments. process leads to an increasing pressure of air within the pleural How common is pneumothorax? cavity and haemodynamic compromise because of impaired venous return and decreased cardiac output. Treatment is with Between 1991 and 1995 annual consultation rates for high flow oxygen and emergency needle decompression with pneumothorax in England were reported as 24/100 000 for men a cannula inserted in the second intercostal space in the and 9.8/100 000 for women, and admission rates were 16.7/100 midclavicular line.
    [Show full text]
  • Spontaneous Pneumothorax in COVID-19 Patients Treated with High-Flow Nasal Cannula Outside the ICU: a Case Series
    International Journal of Environmental Research and Public Health Case Report Spontaneous Pneumothorax in COVID-19 Patients Treated with High-Flow Nasal Cannula outside the ICU: A Case Series Magdalena Nalewajska 1, Wiktoria Feret 1 , Łukasz Wojczy ´nski 1, Wojciech Witkiewicz 2 , Magda Wi´sniewska 1 and Katarzyna Kotfis 3,* 1 Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70–111 Szczecin, Poland; [email protected] (M.N.); [email protected] (W.F.); [email protected] (Ł.W.); [email protected] (M.W.) 2 Department of Cardiology, Pomeranian Medical University, 70–111 Szczecin, Poland; [email protected] 3 Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70–111 Szczecin, Poland * Correspondence: katarzyna.kotfi[email protected] Abstract: The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic and a burden to global health at the turn of 2019 and 2020. No targeted treatment for COVID-19 infection has been identified so far, thus supportive treatment, invasive and non-invasive oxygen support, and corticosteroids remain a common therapy. High-flow nasal cannula (HFNC), a non-invasive oxygen support method, has become a prominent treatment option for respiratory failure during the SARS-CoV-2 pandemic. Citation: Nalewajska, M.; Feret, W.; HFNC reduces the anatomic dead space and increases positive end-expiratory pressure (PEEP), Wojczy´nski,Ł.; Witkiewicz, W.; allowing higher concentrations and higher flow of oxygen. Some studies suggest positive effects of Wi´sniewska,M.; Kotfis, K. HFNC on mortality and avoidance of intubation.
    [Show full text]
  • Allergic Bronchopulmonary Aspergillosis: a Perplexing Clinical Entity Ashok Shah,1* Chandramani Panjabi2
    Review Allergy Asthma Immunol Res. 2016 July;8(4):282-297. http://dx.doi.org/10.4168/aair.2016.8.4.282 pISSN 2092-7355 • eISSN 2092-7363 Allergic Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity Ashok Shah,1* Chandramani Panjabi2 1Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India 2Department of Respiratory Medicine, Mata Chanan Devi Hospital, New Delhi, India This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. In susceptible individuals, inhalation of Aspergillus spores can affect the respiratory tract in many ways. These spores get trapped in the viscid spu- tum of asthmatic subjects which triggers a cascade of inflammatory reactions that can result in Aspergillus-induced asthma, allergic bronchopulmo- nary aspergillosis (ABPA), and allergic Aspergillus sinusitis (AAS). An immunologically mediated disease, ABPA, occurs predominantly in patients with asthma and cystic fibrosis (CF). A set of criteria, which is still evolving, is required for diagnosis. Imaging plays a compelling role in the diagno- sis and monitoring of the disease. Demonstration of central bronchiectasis with normal tapering bronchi is still considered pathognomonic in pa- tients without CF. Elevated serum IgE levels and Aspergillus-specific IgE and/or IgG are also vital for the diagnosis. Mucoid impaction occurring in the paranasal sinuses results in AAS, which also requires a set of diagnostic criteria. Demonstration of fungal elements in sinus material is the hall- mark of AAS.
    [Show full text]
  • Editorial Note on Pulmonary Fibrosis Sindhu Sri M*
    Editorial Note iMedPub Journals Archives of Medicine 2020 www.imedpub.com Vol.12 No. ISSN 1989-5216 4:e-105 DOI: 10.36648/1989-5216.12.4.e-105 Editorial Note on Pulmonary Fibrosis Sindhu Sri M* Department of Pharmaceutical Analytical Chemistry, Jawaharlal Nehru Technological University, Hyderabad, India *Corresponding author: Sindhu Sri M, Department of Pharmaceutical Analytical Chemistry, Jawaharlal Nehru Technological University, Hyderabad, India, E-mail: [email protected] Received date: July 20, 2020; Accepted date: July 26, 2020; Published date: July 31, 2020 Citation: Sindhu Sri M (2020) Editorial Note on Pulmonary Fibrosis. Arch Med Vol. 12 Iss.4: e105 Copyright: ©2020 Sindhu Sri M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Editorial Note • Lung fibrosis or pulmonary fibrosis. • Liver fibrosis. Pulmonary Fibrosis (PF) is a lung disease that happens when • Heart fibrosis. lung tissue gets harmed and scarred. Pulmonary meaning lung, • Mediastinal fibrosis. and fibrosis significance scar tissue. In the medical terminology • Retroperitoneal cavity fibrosis used to depict this scar tissue is fibrosis. The alveoli and the • Bone marrow fibrosis veins inside the lungs are responsible for conveying oxygen to • Skin fibrosis the body, including the brain, heart, and different organs. The • Scleroderma or systemic sclerosis PF group of lung diseases falls into a considerably large Hypoxia caused by pulmonary fibrosis can lead to gathering of ailments called the interstitial lung infections. At pulmonary hypertension, which, in turn, can lead to heart the point when an interstitial lung ailment incorporates scar failure of the right ventricle.
    [Show full text]
  • 8. Respiratory Pathology Respiratory System Structure and Function [Figs
    8. Respiratory pathology Respiratory system Structure and function [Figs. 8-1, 8-3] • Upper respiratory tract • structure • nasal cavity, sinuses, nasopharynx, • oral cavity, oropharynx • function • filter, warm, humidify air • Lower respiratory tract • structure • larynx, trachea • lungs (right and left) • function • air exchange • speech • Branching of airways into smaller ducts • bronchi → bronchioles → alveolar ducts → alveoli • Air exchange occurs in most distal spaces (alveoli) • diffusion barrier [Fig. 8-3] • alveolar pneumocyte, common basement membrane, endothelial cell • Respiratory defense mechanisms • mucus, mucocilliary escalator • alveolar macrophages • cough/ sneeze reflexes • Pulmonary circulation • dual blood supply Respiratory pathology Overview • Infections • Obstructive airway diseases • Restrictive airway diseases • Miscellaneous disorders • Neoplasms Infections of the upper respiratory tract • Common cold, sore throat, “Flu” • viral infection of upper respiratory tract with classic symptoms • rhinovirus, parainfluenza viruses • self limited, symptomatic relief • Strep throat • a bacterial infection caused by streptococcus A • diagnosed by identifying the bacteria, antibiotic therapy • Mononucleosis • a viral infection caused by EBV with enlarged nodes, sore throat • Diphtheria • a bacterial infection of the throat with formation of a membrane Respiratory pathology Infections, middle respiratory tract [Fig. 8-5] • Croup (3mo -3yo) • acute viral infection of the larynx in children younger than 3 yo • barking cough •
    [Show full text]
  • Pneumothorax in Patients with Idiopathic Pulmonary Fibrosis
    Yamazaki et al. BMC Pulm Med (2021) 21:5 https://doi.org/10.1186/s12890-020-01370-w RESEARCH ARTICLE Open Access Pneumothorax in patients with idiopathic pulmonary fbrosis: a real-world experience Ryo Yamazaki, Osamu Nishiyama* , Kyuya Gose, Sho Saeki, Hiroyuki Sano, Takashi Iwanaga and Yuji Tohda Abstract Background: Some patients with idiopathic pulmonary fbrosis (IPF) develop pneumothorax. However, the charac- teristics of pneumothorax in patients with IPF have not been elucidated. The purpose of this study was to clarify the clinical course, actual management, and treatment outcomes of pneumothorax in patients with IPF. Methods: Consecutive patients with IPF who were admitted for pneumothorax between January 2008 and Decem- ber 2018 were included. The success rates of treatment for pneumothorax, hospital mortality, and recurrence rate after discharge were examined. Results: During the study period, 36 patients with IPF were admitted with pneumothorax a total of 58 times. During the frst admission, 15 patients (41.7%) did not receive chest tube drainage, but 21 (58.3%) did. Of the 21 patients, 8 (38.1%) received additional therapy after chest drainage. The respective treatment success rates were 86.6% and 66.7% in patients who underwent observation only vs chest tube drainage. The respective hospital mortality rates were 13.3% and 38.0%. The total pneumothorax recurrence rate after hospital discharge was 34.6% (n 9). = Conclusions: Pneumothorax in patients with IPF was difcult to treat successfully, had a relatively poor prognosis, and showed a high recurrence rate. Keywords: Idiopathic pulmonary fbrosis, Hospitalization, Pneumothorax, Recurrence, Treatment Background pneumothorax was signifcantly associated with poor Idiopathic pulmonary fbrosis (IPF) is a specifc form survival in patients with IPF [11].
    [Show full text]
  • Secondary Spontaneous Pneumothorax in a Patient of Allergic Bronchopulmonary Aspergillosis: an Unusual Presentation
    International Journal of Research in Medical Sciences Sandal S et al. Int J Res Med Sci. 2021 Apr;9(4):1205-1208 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20211377 Case Report Secondary spontaneous pneumothorax in a patient of allergic bronchopulmonary aspergillosis: an unusual presentation Shivali Sandal1, Surender Kumar2* 1Department of Critical Care Medicine, Inderaprastha Apollo, New Delhi, India 2Department of Cardiology, UN Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India Received: 23 January 2021 Accepted: 01 March 2021 *Correspondence: Dr. Surender Kumar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Allergic bronchopulmonary aspergillosis (ABPA) is a complex immunologic pulmonary disorder caused by hypersensitivity to fungus, Aspergillus fumigates. It clinically manifests with non-specific respiratory and systemic symptoms. ABPA is typically seen in patients with long-standing asthma or cystic fibrosis. Pleural involvement in ABPA is uncommon and secondary spontaneous pneumothorax is very rare. Herein, we report a case of 33 years old male patient presented with dyspnoea, low grade fever and productive cough. High Resolution Computed tomography (HRCT) scan of thorax was suggestive of ABPA with secondary pneumothorax. Keywords: Allergic bronchopulmonary aspergillosis, Aspergillus fumigates, High resolution computed tomography, Secondary spontaneous pneumothorax INTRODUCTION episodes of increasing dyspnea, cough with sputum production, pleuritic pain and fever.
    [Show full text]
  • Community Acquired Pneumonia Sonia Akter*, Shamsuzzaman and Ferdush Jahan
    Akter et al. Int J Respir Pulm Med 2015, 2:1 International Journal of ISSN: 2378-3516 Respiratory and Pulmonary Medicine Review Article : Open Access Community Acquired Pneumonia Sonia Akter*, Shamsuzzaman and Ferdush Jahan Department of Microbiology, Dhaka Medical College, Bangladesh *Corresponding author: Sonia Akter, Department of Microbiology, Dhaka Medical College, Dhaka, Bangladesh, E-mail: [email protected] or residing in a long term care facility for > 14 days before the onset Abstract of symptoms [4]. Diagnosis depends on isolation of the infective Community-acquired pneumonia (CAP) is typically caused by organism from sputum and blood. Knowledge of predominant an infection but there are a number of other causes. The most microbial patterns in CAP constitutes the basis for initial decisions common type of infectious agents is bacteria such as Streptococcus about empirical antimicrobial treatment [5]. pneumonia. CAP is defined as an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the Microbial Pathogens community. CAP remains a common and potentially serious illness. It is associated with considerable morbidity, mortality and treatment Strep. pneumoniae accounted for over 80 percent of cases of cost, particularly in elderly patients. CAP causes problems like community-acquired pneumonia in the era before penicillin [6]. difficulty in breathing, fever, chest pains, and cough. Definitive Strep. pneumoniae is still the single most common defined pathogen clinical diagnosis should be based on X-ray finding and culture in nearly all studies of hospitalized adults with community-acquired of lung aspirates. The chest radiograph is considered the” gold pneumonia [7-9]. Other bacteria commonly encountered in cultures of standard” for the diagnosis of pneumonia but cannot differentiate bacterial from non bacterial pneumonia.
    [Show full text]
  • Swine Pneumonia
    L-5203 6/98 Swine Pneumonia Bruce Lawhorn* neumonia is an important disease of the lower respiratory tract that impairs animal health and lowers individual and herd Pperformance in swine. “Pneumonia” means inflamma- tion of the lungs. It may be minor, subsiding quickly, or develop into advanced pneumonia. The cause of the lung inflammation and the devel- opment of complications, such as secondary bacterial infection, generally determine how severe pneumonia becomes. Coughing and “thumping”(shallow, rapid breathing) are typical symptoms of pneumonia in swine. As the pneumonia becomes more severe, appe- tite and growth rate decrease, feed is utilized less effi- ciently, hogs may become chronic poor-doers, death may occur and treatment and control costs escalate. Possible causes of pneumonia are bacteria, viruses, parasites, extreme daily temperature fluctuations, chemicals (manure gas), dust and other respiratory tract irritants from the environment. Most of these are in- haled into the lungs. Infectious agents such as certain bacteria may reach the lungs through the blood stream. Parasites reach the lungs by larval migration through blood vessels, tissues and organs. defenses, predisposing them to secondary infection by Atrophic rhinitis and upper respiratory system dis- Pasteurella multocida and other bacteria. The second- ease in swine are discussed in the Extension fact sheet ary infection makes the lower respiratory disease worse L-2193, “Atrophic Rhinitis.” than with the M. hyopneumoniae infection alone. Bacterial Causes The combination of infections, first with M. hyopneumoniae, then with P. multocida, is considered Mycoplasma hyopneumoniae, the pneumonia agent the most frequent form of pneumonia, and is called present in virtually all swine herds, is transmitted from “common swine pneumonia” or enzootic pneumonia.
    [Show full text]
  • Cryptogenic Organizing Pneumonia
    462 Cryptogenic Organizing Pneumonia Vincent Cottin, M.D., Ph.D. 1 Jean-François Cordier, M.D. 1 1 Hospices Civils de Lyon, Louis Pradel Hospital, National Reference Address for correspondence and reprint requests Vincent Cottin, Centre for Rare Pulmonary Diseases, Competence Centre for M.D., Ph.D., Hôpital Louis Pradel, 28 avenue Doyen Lépine, F-69677 Pulmonary Hypertension, Department of Respiratory Medicine, Lyon Cedex, France (e-mail: [email protected]). University Claude Bernard Lyon I, University of Lyon, Lyon, France Semin Respir Crit Care Med 2012;33:462–475. Abstract Organizing pneumonia (OP) is a pathological pattern defined by the characteristic presence of buds of granulation tissue within the lumen of distal pulmonary airspaces consisting of fibroblasts and myofibroblasts intermixed with loose connective matrix. This pattern is the hallmark of a clinical pathological entity, namely cryptogenic organizing pneumonia (COP) when no cause or etiologic context is found. The process of intraalveolar organization results from a sequence of alveolar injury, alveolar deposition of fibrin, and colonization of fibrin with proliferating fibroblasts. A tremen- dous challenge for research is represented by the analysis of features that differentiate the reversible process of OP from that of fibroblastic foci driving irreversible fibrosis in usual interstitial pneumonia because they may determine the different outcomes of COP and idiopathic pulmonary fibrosis (IPF), respectively. Three main imaging patterns of COP have been described: (1) multiple patchy alveolar opacities (typical pattern), (2) solitary focal nodule or mass (focal pattern), and (3) diffuse infiltrative opacities, although several other uncommon patterns have been reported, especially the reversed halo sign (atoll sign).
    [Show full text]
  • Chronic Respiratory Disease Strategic Plan, January 2017
    Chronic Respiratory Disease Strategic Plan As Required By S.B. 200, Sec. 2.31, 84th Legislature, Regular Session, 2015 Department of State Health Services January 2017 - This page is intentionally left blank - Table of Contents Executive Summary .......................................................................................................................3 Introduction ....................................................................................................................................5 Background ....................................................................................................................................5 Estimated Annual Direct and Indirect State Health Care Costs ...............................................8 Asthma .........................................................................................................................................8 Medicaid .................................................................................................................................. 8 Absenteeism Cost for Asthma ................................................................................................. 8 State of Texas Employees Previously Diagnosed with Asthma .............................................. 8 COPD ...........................................................................................................................................8 Medicaid .................................................................................................................................
    [Show full text]
  • Macrolide Therapy in Cryptogenic Organizing Pneumonia: a Case Report and Literature Review
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 9: 829-834, 2015 Macrolide therapy in cryptogenic organizing pneumonia: A case report and literature review QUN‑LI DING, DAN LV, BI‑JIONG WANG, QIAO‑LI ZHANG, YI‑MING YU, SHI‑FANG SUN, ZHONG-BO CHEN, HONG-YING MA and ZAI-CHUN DENG Department of Respiratory Medicine, Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang 315020, P.R. China Received May 9, 2014; Accepted December 15, 2014 DOI: 10.3892/etm.2015.2183 Abstract. Cryptogenic organizing pneumonia (COP) is a pneumonia (1,2). Secondary OP is associated with a number of pulmonary disorder associated with nonspecific clinical entities, including drugs, infections, malignancies, connective presentations. The macrolide class of antimicrobial agents is tissue diseases, organ transplantation, radiotherapy and the widely used to treat infectious and inflammatory respiratory inhalation of harmful gases. COP mainly involves the alveoli, diseases in humans. The present study reports a case of COP alveolar ducts and small airways; however, the lung intersti- that was effectively treated with azithromycin in combination tium may also be involved. It is considered as an inflammatory with glucocorticoid. A literature review of similar cases is disease and diagnosed based on the clinical, radiographic and also presented. It was found that all COP patients in the litera- pathological findings following the exclusion of diseases asso- ture received macrolide treatment, including six cases with ciated with secondary OP (3). Glucocorticoids are effective in unknown clinical outcomes. For the remaining 29 patients, the treatment of COP. However, glucocorticoids usually take a 20 patients initially received the macrolide as a single therapy longer time to take effect, and this results in severe side-effects.
    [Show full text]